Despite having left people more exposed to the delta variant now, the strategy helped protect the most vulnerable during the second wave, so was the right call.
Articles on Coronavirus vaccines
Displaying 21 - 40 of 125 articles
Two doses have always been more protective than one, but the delta variant has made the benefit of a second vaccine much greater.
World leaders have called for an end to the pandemic – but the numbers don’t add up.
Upwards of 60% of the world needs to be vaccinated to suppress COVID-19 – even with an extra billion doses, that target looks very far away.
Various companies use different ingredients and different delivery systems in their COVID-19 vaccines. Researchers are investigating whether it’s better for individuals to mix what’s available.
Vaccinated people can still get infected with the coronavirus. So if you have symptoms of COVID-19, getting tested can protect others and help health officials keep an eye on the virus.
The increased infectiousness of B16172 could magnify the impact of vaccines being less effective against it.
Surge vaccination is being used to combat the B16172 variant, while the government prepares for a vaccine booster programme.
This is a transcript of episode 15 of The Conversation Weekly podcast, which includes a story on the discovery of microscopic fungi at the world’s largest seed bank.
Reports of fully vaccinated people getting infected with coronavirus shouldn’t cause alarm.
Increased demand and falling supplies in India risk leaving many countries empty handed.
A transcript of episode 14 of The Conversation Weekly podcast, including how people make their life’s biggest decisions.
Plus, a psychologist on how we look back at our big decisions in life. Listen to episode 14 of The Conversation Weekly podcast.
Pressure is mounting to get COVID vaccines to where they are most needed.
It’s easy to call Australian Olympians who receive their COVID shot early ‘queue jumpers’. But the argument for them having early access to the vaccine is more nuanced. Here’s why.
India and South Africa are pressing the World Trade Organization to waive patent rights to help ramp up vaccine production. There’s a better solution.
The vaccine rollout was thrown into fresh uncertainty on Thursday night after the government received medical advice against using the AstraZeneca vaccine for people under 50 because of the very small risk of blood clots.
All vaccines and medications come with risks. But the risks of delaying vaccination are far higher.
We need to stop relying on small GP clinics and urgently move towards using mass vaccination hubs like stadiums, schools and parks.
When your back’s against the wall, attack is not necessarily the best means of defence. With this in mind, the word from Scott Morrison to his ministers is, lay off the states.
Top contributors
-
Professorial Fellow, University of Canberra
-
Professor of Medicine, University of East Anglia
-
Principal Lecturer, Microbiology and Biomedical Science Practice, Fellow of the Institute of Biomedical Science, University of Brighton
-
Associate Professor of Biology, Rochester Institute of Technology
-
Early Career Research Leader, Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University
-
Associate Professor of Marketing, University of Technology Sydney
-
Associate Professor of Health Law, Policy and Management, Boston University
-
FAPESP-Postdoctoral Researcher at the Laboratory of Structural Biology and Zoochemistry, IB/RC (UNESP), University of São Paulo State
-
Professor, School of Population Health, UNSW
-
Senior Lecturer in Biochemistry and Cell Biology, University College Cork
-
Dean of the National School of Tropical Medicine and Professor of Pediatrics and Molecular Virology & Microbiology, Baylor College of Medicine
-
Senior Research Fellow in Global Health, University of Southampton
-
Professor, Languages, Literatures and Cultures, Queen's University, Ontario
-
Professor of Economics, University of Birmingham
-
Clinical professor, University of Glasgow